Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):430–438. doi: 10.1097/QAI.0000000000000610

Table 1.

Samples used for analysis.

Prevalence Incidence Participants
tested
Participants
with discordant
test resultsa
Samples
evaluatedb
Samples classified
as HIV positivec
Tanzania 5.9% 0.78% 9,041 187 (2.1%) 127 (67.9%) 24 (18.9%)
South Africa 21.8% 2.3% 25,772 68 (0.3%) 46 (67.6%) 5 (10.9%)
  Soweto 14.1% 1.18% 13,929 22 (0.2%) 16 (72.7%) 3 (18.8%)
  Vulindlela 30.8% 3.90% 11,843 46 (0.4%) 30 (65.2%) 2 (6.7%)
Total 17.7% 1.85% 34,813 255 (0.7%) 173 (67.8%) 29 (16.8%)
a

Samples were tested in-country using two HIV rapid tests. The number and percentage of samples that had discordant HIV rapid test results (one reactive result and one non-reactive result) are shown.

b

Samples from 173 study participants were evaluated in this study. Samples from the remaining 82 participants who had discordant HIV rapid test results were not evaluated for the following reasons: insufficient plasma available (N=80), in-country sample contamination (N=1), and in-country sample mix-up (N=1).

c

Samples were classified as HIV positive or HIV negative using the testing algorithm shown in Figure 1. The number and percentage of samples evaluated in this study that were classified as HIV positive are shown.